LCTX vs PCG · rev $9.5M vs P/E 13, $37.68B cap
Lineage Cell Therapeutics Inc (LCTX) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
PCG does not have a complete income-statement cache yet.
LCTX currently screens at market cap $213.6M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the LCTX and PCG stock pages for the full models.
Not investment advice.